详细说明
Species Reactivity
Mouse
Specificity
Detects mouse CCL3/MIP‑1 alpha in direct ELISAs.
Source
Monoclonal Rat IgG 1 Clone # 756605
Purification
Protein A or G purified from hybridoma culture supernatant
Immunogen
E. coli-derived recombinant mouse CCL3/MIP-1 alpha
Ala24-Ala92
Accession # P10855Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated
Applications
Recommended
ConcentrationSample
Neutralization
Measured by its ability to neutralize CCL3/MIP‑1 alpha -induced chemotaxis in the BaF3 mouse pro‑B cell line transfected with human CCR5. The Neutralization Dose (ND 50) is typically 0.125-0.75 µg/mL in the presence of 10 ng/mL Recombinant Mouse CCL3/MIP‑1 alpha.
Please Note: Optimal dilutions should be determined by each laboratory for each application. are available in the Technical Information section on our website.
Data Examples
Neutralization | Chemotaxis Induced by CCL3/MIP-1 alpha and Neutralization by Mouse CCL3/MIP-1 alpha Antibody. Recombinant MouseCCL3/MIP-1 alpha (Catalog # ) chemoattracts the BaF3 mouse pro-B cell line transfected with human CCR5 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # ). Chemotaxis elicited by Recombinant Mouse CCL3/MIP-1 alpha (10 ng/mL) is neutralized (green line) by increasing concentrations of Rat Anti-Mouse CCL3/MIP-1 alpha Monoclonal Antibody (Catalog # MAB450). The ND50 is typically 0.125-0.75 µg/mL. |
Preparation and Storage
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CCL3/MIP-1 alpha
CCL3, also known as Macrophage Inflammatory Protein 1 alpha (MIP-1 alpha ) and LD78, is a member of the beta or CC subfamily of chemokines and is closely related to CCL4/MIP-1 beta. Chemokines comprise a large family of small secreted proteins that are involved in immune and inflammatory responses. CCL3 expression can be induced in a variety of hematopoietic cells, fibroblasts, smooth muscle cells, and epithelial cells (1). Mature mouse CCL3 shares 73%, 91%, and 82% amino acid sequence identity with human, rat, and cotton rat CCL3, respectively (2). CCL3 is an approximately 8 kDa chemokine that forms complexes with sulfated proteoglycans (3, 4). In a reversible process, CCL3 associates into noncovalently-linked dimers which then form tetramers and high molecular weight polymers (5, 6). These complexes of CCL3 are protected from proteolytic digestion by Insulin Degrading Enzyme (IDE) which can cleave the monomeric chemokine (6). CCL3 exerts its biological functions through interactions with CCR1, CCR3, and CCR5 (1). It is cleared from the extracellular space by internalization via the decoy chemokine receptor D6 (7). CCL3 promotes the chemoattraction, adhesion to activated vascular endothelium, and cellular activation of many hematopoietic cell types including activated T cells, NK cells, neutrophils, monocytes, immature dendritic cells, and eosinophils (1, 8-10). CCL3 is also known as Stem Cell Inhibitor (SCI) and can inhibit the proliferation of hematopoietic progenitor cells (3). CCL3 bioactivity contributes to tumor metastasis and the inflammatory components of viral infection, rheumatoid arthritis, and hepatitis (11-14), although it also can suppress the replication of HIV (15). CCL3 additionally promotes hyperalgesia by sensitizing sensory neurons to TRPV1-mediated noxious stimulation (16).
References:
Menten, P. et al. (2002) Cytokine Growth Factor Rev. 13:455.
Davatelis, G. et al. (1988) J. Exp. Med. 167:1939.
Graham, G.J. et al. (1990) Nature 344:442.
Wagner, L. et al. (1998) Nature 391:908.
Graham, G.J. et al. (1994) J. Biol. Chem. 269:4974.
Ren, M. et al. (2010) EMBO J. 29:3952.
Weber, M. et al. (2004) Mol. Biol. Cell 15:2492
Taub, D.D. et al. (1993) Science 260:355.
Bernardini, G. et al. (2008) Blood 111:3626.
Lee, S.C. et al. (2000) J. Immunol. 164:3392.
Wu, Y. et al. (2008) J. Immunol. 181:6384.
Cook, D.N. et al. (1995) Science 269:1583.
Chintalacharuvu, S.R. et al. (2005) Immunol. Lett. 100:202.
Ajuebor, M.N. et al. (2004) Eur. J. Immunol. 34:2907.
Cocchi, F. et al. (1995) Science 270:1811.
Zhang, N. et al. (2005) Proc. Natl. Acad. Sci. 102:4536.
Entrez Gene IDs:
6348 (Human); 20302 (Mouse); 25542 (Rat); 448787 (Canine)
Alternate Names:
C-C motif chemokine 3; MIP1-(a); AI323804; CCL3; chemokine (C-C motif) ligand 3; G0S19-1; LD78a; LD78alpha; MIP1 alpha; MIP-1 alpha; Mip1a; MIP-1alpha; MIP1-alpha; Scya3